ArticleIranian journal of pharmaceutical research : IJPR2011
Production and Evaluation of Chitosan from Aspergillus Niger MTCC Strains.
Article in Iranian journal of pharmaceutical research : IJPR, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Saccharomyces Cerevisiae as an Untapped Source of Fungal Chitosan for Antimicrobial Action.Applied biochemistry and biotechnology · 2021Article
- Biostimulants for the Regulation of Reactive Oxygen Species Metabolism in Plants under Abiotic Stress.Cells · 2021Review
- Development of Stimuli-Responsive Chitosan/ZnO NPs Transdermal Systems for Controlled Cannabidiol Delivery.Polymers · 2021Article
- Interrogation of the cell wall integrity pathway inGene: X · 2020Article
- Chitosan as a Wound Dressing Starting Material: Antimicrobial Properties and Mode of Action.International journal of molecular sciences · 2019Review
- Nanosilver-marine fungal chitosan as antibiotic synergizers against sepsis fish bacteria.Iranian journal of microbiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three different Aspergillus Niger MTCC strains (872, 1785 and 2208) were used for the production of chitosan. Multivariate growth mediums in varying incubation periods were analyzed for the production. The produced chitosan was characterized by its physical appearance, moisture content (by means of gravimetric method), percentage of ash and solubility (through the Association of Official Agricultural Chemists (AOAC) methods) and also the degree of deacetylation (with Infrared spectroscopy). The infrared (IR) spectrum of produced fungal chitosan shows strong similarity with the IR spectrum of commercial chitosan. Our experimental results concluded that the maximum yield of chitosan (26.1%) was obtained from Aspergillus niger MTCC 2208 grown in supplemented Potato Dextrose Broth (PDB) medium, incubated at 30°C for 120 h in 180 rpm. The antimicrobial activity of produced chitosan was tested against five bacteria by Disc diffusion technique, which confirmed that chitosan have minimal antimicrobial activity.
Indexed as
Identifiers
24250388PMC3813029What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.